The suits were filed in rapid succession in the days after the NIH announced on February 7 that it would cap so-called ...

No treatment or drug gets to market without a clinical trial. Many of those trials don’t just happen in academic settings, ...

It began one hot summer morning as I awoke in the thorny embrace of brambles in a hedge on the South Downs, UK. The bicycle between my legs had morphed from transport to sleeping pallet. Marking ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

The Philadelphia market has gained recognition not only for its cell and gene therapy sector but also its real estate scene and talent pool. Vittoria Biotherapeutics, Interius BioTherapeutics and ...

Recommendations from the Act 167 report in Vermont state that the University of Vermont Health Network “should reevaluate whether its medical education and research programs are contributing to better ...

The Trump administration has targeted $4 billion in cuts to “indirect” costs for NIH research grants. Those funds, typically known as overhead, help cover the facilities and support that enable ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

The Foundation for a Healthy Kentucky's latest Health for a Change webinar focused on cancer disparities in Eastern Kentucky, ...

The National Institutes of Health updated policies to establish a 15% cap on how much the agency will provide for indirect costs related to research.

Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults. The study questions the assumption that Paxlovid’s effectiveness in reducing COVID-19 ...

Professor Tim Koh, who receives his project funding through the National Institutes of Health, said if his funding is not ...